Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer?

Detalles Bibliográficos
Autores principales: Abdul Wahid, Maryam, Hussain, Hassan ul, Ghouri, Hafsa, Khan, Tarneem, Rehan, Syeda Tayyaba, Mumtaz, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583937/
https://www.ncbi.nlm.nih.gov/pubmed/37352527
http://dx.doi.org/10.1097/JS9.0000000000000550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583937/
https://www.ncbi.nlm.nih.gov/pubmed/37352527
http://dx.doi.org/10.1097/JS9.0000000000000550

Ejemplares similares